Better Interventional Therapies are Needed to Counter the Global Rise of Vascular Disease
10+ million arterial and venous interventions are performed every year, with demand and disease incidence rising. Scalable, cost-effective solutions are urgently needed, but developing them can be challenging.
Endovascular Arterial Therapies are Forcing Physicians to Make Tradeoffs
Interventionalists are performing complex procedures with hard-to-use, overpriced tools that come with too many risks of adverse events. Safer, more effective options are needed, but many of the most promising technologies get bogged down in development, regulatory, or reimbursement challenges and never see the light of day.
Widespread Chronic Venous Insufficiency Demands a New Generation of Therapeutics
Nearly 200 million adults worldwide have chronic venous insufficiency (CVI), but the disease is widely undertreated. The global rise of CVI demands new therapeutics that are effective and scalable. With decades of experience in the manufacturing and commercialization of endovasccular devices, we identify solutions and expedite their approval for physicians & patients.